Description
CJC-1295 with DAC is a long-acting synthetic GHRH analog featuring a Drug Affinity Complex (DAC) modification that binds covalently to serum albumin, dramatically extending its plasma half-life relative to the no-DAC variant. CJC-1295 with DAC has been studied as a research peptide for sustained GHRH receptor activity in laboratory models.
The DAC modification makes this version of CJC-1295 particularly useful in research applications requiring extended GHRH receptor activation timelines.
Research areas studied
- Long-acting GHRH analog pharmacology
- Albumin-binding peptide pharmacokinetics
- Comparative GHRH analog half-life studies
Quality assurance
- HPLC verified at 99%+ purity
- Certificate of Analysis (COA) available upon request
- Lyophilized in a research-grade facility under controlled conditions
For research purposes only. Not for human consumption, diagnostic, or therapeutic use.